Companies House · 16560988

MYLAN LTD

UK registered company, private limited company, incorporated 5 Jul 2025.

Active

50
Public contracts: 9
Spend payments: £348.1k
Total spend

MYLAN LTD is a UK company registered at Companies House under number 16560988. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number: 16560988
Status: Active
Company type: Private Limited Company
Incorporated: 5 Jul 2025
Country of origin: United Kingdom
Registered office: 111 NEW UNION STREET, COVENTRY, CV1 2NT, ENGLAND
Nature of business (SIC): 47910 - Retail sale via mail order houses or via Internet
Accounts category: NO ACCOUNTS FILED

View source on data.gov.uk

Public sector contracts

Contract awards linked to MYLAN LTD.

Procurement	Buyer	Awarded	Value
NHS National Generic Pharmaceuticals Wave 14a	NHS England	—	—
NHS National Generic Pharmaceuticals - Clozapine	NHS England	—	—
NHS National Generic Pharmaceuticals - Clozapine	NHS England	—	—
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025	NHS England	—	—
NHS National Generic Pharmaceuticals Wave 15b	NHS England	—	—
NHS National Generic Pharmaceuticals Wave 15b	NHS England	—	—
NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed solution for infusion LSNE region	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS Nation Generic Pharmaceuticals - Clozapine	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS Nation Generic Pharmaceuticals - Clozapine	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East	NHS England	—	—
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East	NHS England	—	—
NHS Framework Agreement for Branded Medicines – National	NHS England	—	—
NHS Framework Agreement for Branded Medicines - National Tender	NHS England	—	—
NHS National Pharmaceuticals - Everolimus and terminated agreement products	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS National Pharmaceuticals - Everolimus and terminated agreement products	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS National Pharmaceuticals - Everolimus and terminated agreement products	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS National Pharmaceuticals Transition 2021_3	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS National Pharmaceuticals Transition 2021_3	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS National Pharmaceuticals Transition 2021_3	The NHS Commissioning Board (operating under the name of NHS England)	—	—
Antiviral Generic Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	—	—
Antiviral Generic Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	—	—
Oncology Generics Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	—	—
Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	—	—
Immunosuppressant Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	—	—
Psychiatry Generic Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	—	—
Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Generic Medicine	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
Glatiramer Injection	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	—	—
Glatiramer Injection	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	—	—
NP39722f Lenalidomide	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP47822 Multiple Sclerosis Medicines	The Common Services Industry (more commonly known as NHS National Services Scotland) ("NSS")	—	—
Glatiramer Injection	The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")	—	—
NP31419 Clozapine Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	—	—
NP31419 Clozapine Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	—	—
NHS National Generic Pharmaceuticals Wave 13	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS National Generic Pharmaceuticals Wave 13	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS National Framework for Transition products commencing 1 May 2024	NHS England	—	—
NHS National Framework for Transition products commencing 1 May 2024	NHS England	—	—
NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025	NHS England	—	—
Generic Drugs - Topicals & Miscellaneous	Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)	—	—
Generic Injections/Infusions 4	Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (On Behalf of all Wales) Health Boards	—	—
Generic Anti-Infective Drugs	Velindre NHS Trust, NHS Wales Shared Services Parternship - Procurement Services (On Behalf of All Wales) Health Boards and Trusts	—	—
NHS National Pharmaceuticals Transition 2022_1	NHS England	—	—
NHS National Pharmaceuticals Transition 2022_2	NHS England	—	—

Supplier identities

How this company appears as a supplier across the data.

Recent transparency payments

9 payments recorded, totalling £348,124.

Payer	Description	Date	Amount
united-lincolnshire-hospitals-nhs-trust	PHARMACY PILGRIM	22 Jun 2017	£54.6k
united-lincolnshire-hospitals-nhs-trust	GRANTHAM PHARMACY CREDITORS	22 Jun 2017	£54.6k
united-lincolnshire-hospitals-nhs-trust	PHARMACY	15 Jun 2017	£109.2k
united-lincolnshire-hospitals-nhs-trust	PHARMACY PILGRIM	9 Mar 2017	£25.2k
united-lincolnshire-hospitals-nhs-trust	PHARMACY	9 Mar 2017	£25.2k
united-lincolnshire-hospitals-nhs-trust	GRANTHAM PHARMACY CREDITORS	16 Feb 2017	£25.2k
united-lincolnshire-hospitals-nhs-trust	PHARMACY PILGRIM	9 Feb 2017	£25.2k
united-lincolnshire-hospitals-nhs-trust	PHARMACY	2 Feb 2017	£25.2k
city-of-york-council	Residential Care	27 May 2016	£3.7k

FAQs about MYLAN LTD

Is MYLAN LTD an active company?

MYLAN LTD (company number 16560988) is recorded as "Active", incorporated on 5 Jul 2025.

What does MYLAN LTD do?

Its Companies House nature-of-business (SIC) is: 47910 - Retail sale via mail order houses or via Internet.

Has MYLAN LTD won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

How much public money has MYLAN LTD received?

9 transparency-spend payments totalling £348,124 are recorded against MYLAN LTD.

Where is MYLAN LTD based?

Its registered office is 111 NEW UNION STREET, COVENTRY, CV1 2NT, ENGLAND.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable